← Back to Patent Explorer
US5496846A Expired / Lapsed US ⏱️ 0.0 years remaining

Taxol treatment of breast cancer

Assignee: United States Department of Health and Human Services
•
Filing: 1994-01-06
•
Granted: 1996-03-05
•
Expires: 2014-01-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention is a method of treatment for a patient with cancer. In particular, it is a method of treating patients having breast cancer using the microtubule agent, Taxol. The present method of administration, serves to prevent or retard the adverse side effects associated with Taxol and reduces the chances of a patient developing mdr Taxol resistance. The novel method of treatment provides a low-dose, longterm exposure to Taxol in a patient.

Inventors

  • 👤 Wyndham H. Wilson
  • 👤 Robert Wittes

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 07:15
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61P; A61P35/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 86 words
A method of treating a patient suffering from breast cancer, which comprises: (a) intravenously infusing taxol into said patient at a continuous dosage rate of between 17.5 to 35 milligrams of taxol per square meter of patient surface area per 24 hours to infuse between 70 and 140 milligrams of taxol per square meter of patient surface area into said patient over a period of 96 hours; and (b) repeating said step (a) in 21 day cycles until remission of said patient's breast cancer is obtained.
Claim 2
Independent Claim 86 words
A method of treating a patient suffering from breast cancer, which comprises: (a) intravenously infusing taxol into said patient at a continuous dosage rate of between 17.5 to 35 milligrams of taxol per square meter of patient surface area per 24 hours to infuse between 70 and 140 milligrams of taxol per square meter of patient surface area into said patient over a period of 96 hours; and (b) repeating said step (a) in 21 day cycles until remission of said patient's breast cancer is obtained.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-03-05 1999-09-04 2000-03-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-03-05 2003-09-04 2004-03-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-03-05 2007-09-04 2008-03-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag